AAV2-mediated gene delivery of sFasL as a neuroprotective therapy in glaucoma

摘要

Method for treating glaucoma and / or Fas ligand-dependent inflammatory conditions in a subject using a soluble Fas ligand (sFasL) or fragment thereof, which may be rAAV mediated delivery of sFasL or fragment thereof to the subject .